Skip to main content

Editorial Advisors and Editorial Board Members

Editorial Board Members
 

Cardiovascular

Fares Al-Ahdab, MD, MSc, Houston Methodist Academic Institute, USA
Fares Al-Ahdaborcid.org/0000-0001-5481-696X
Research interests: Global burden of cardiovascular disease, machine learning, preventive cardiology, nuclear cardiology, systematic review, meta-analysis, echocardiography, cardiac computed tomography angiography

Dr. Fares Al-Ahdab is a physician-scientist with expertise in the areas of research methods and epidemiology, bioinformatics and machine learning, preventive cardiology and nuclear cardiology, along with his long-time research work in the areas of evidence-based medicine, evidence synthesis (systematic reviews and meta-analyses), clinical guidelines and clinical guidelines development. He has published more than 180 peer-reviewed scientific publications including clinical guidelines and authoritative papers, in top-tier journals including The Lancet, BMJ, JAMA, JACC, among others. He has long served as a referee for top journals also, including The Lancet, BMJ, many BMC journals, among others, and an senior/associate editor with several peer-reviewed journals. Dr. Alahdab enjoys medical education and mentorship (on both ends of the transaction) and is an avid reader of nonfiction books. Webpage.

Anping Cai, MD, PhD, Guangdong Provincial People's Hospital and Guangdong Cardiovascular Institute, China
Anping Cai picorcid.org/0000-0003-3953-5881
Research interests: Hypertension, heart failure, health disparities

Anping Cai (MD PhD) is currently a cardiologist in Guangdong Provincial People’s Hospital and Guangdong Cardiovascular Institute. He is interested in the use of data from population-based study to evaluate the prevalence and potential modifiable risk factors of hypertension and heart failure. In addition, he is also interested in studying the factors related to health disparities. His current research is focused on the burden of hypertension and related cardiovascular disease in the community; and using cardiovascular imaging and plasma biomarker to timely identify people with hypertension who are at high risk of developing cardiovascular events. In addition, his research is also focused on management and outcomes in hospitalized patients with heart failure from registry study, aiming to identify prognostic factors that can be intervened so as to improve the outcomes for these population groups. Furthermore, Dr. Cai is also very interested in health disparities incurred by socioeconomic status and sex/gender. Webpage.

Tao Chen, PhD, Liverpool School of Tropical Medicine, UK
Tao Chenorcid.org/0000-0002-5489-6450
Research interests: Diabetes, cardiovascular disease, stroke, clinical trial, medical statistics, trial-based or model-based health economics evaluation, clinical epidemiology, system review and meta-analysis

Tao Chen earned his first degree in medicine (2006), followed by MSc (2009) and PhD (2012) in Epidemiology and Biostatistics from Peking Union Medical College. He joined the Centre for Health Economics at University of York from Nov 2022. Prior to his role at York, he worked at University of Liverpool, Liverpool School of Tropic Medicine, King’s College London and Nanjing Medical University in China.His research includes: 1) the trial based or model-based economic evaluation. 2) Statistical issues in design, analysis and reporting in clinical trials for medical and public health problems. 3) Disease modelling to assess the clinical and cost impacts from breakthrough trials or health policies locally and globally 4) Epidemiological study in non-communicable diseases, particularly in cardiometabolic diseases. Webpage.

Chengming Fan, MD, PhD, The Second Xiangya Hospital, Central South University, China
Chengming Fan picorcid.org/0000-0003-0497-1798
Research interests: Clinic practice, cardiovascular surgery, treatment of ischemic heart disease with human induced pluripotent stem cells (hiPSC)-related strategy and with preclinical animal models

Dr. Chengming Fan was featured in the list of Most Active Scholars in Global Cardiovascular Surgery Research in 2021. Dr. Fan's research has received support from grants provided by the National Natural Science Foundation of China, the Hunan Provincial Excellent Youth Science Foundation, and the Hunan Provincial Excellent Postdoctoral Foundation. He has authored over 50 academic papers in national and international journals, boasting an H-index of 14. Webpage.

Min Gao, PhD, University of Oxford, UK
Min Gao headshotorcid.org/0000-0001-6196-7088
Research interests: Diet, health behaviour, cohort study, cardiovascular disease, diabetes, mental illness, health behaviour, obesity, cardiometabolism, BMI, biobank

Dr Gao is an epidemiologist and health behaviour scientist at University of Oxford. Dr Gao has a particular interest in understanding how health behaviours and obesity impact cardiovascular disease, diabetes, mental health, etc. Dr Gao is experienced in analysing longitudinal data, primary care datasets across behavioural science and health policy. In the meantime, Dr Gao has conducted several systematic reviews and several clinical trials to help patients manage their weight and health behaviours. Webpage. 

Frederick Ho, PhD, University of Glasgow, UK
Frederick Ho headshotorcid.org/0000-0001-7190-9025
Research interests: epidemiology, statistics, cardiovascular, public health

Dr Frederick Ho is a Lecturer in Public Health at the School of Health and Wellbeing, University of Glasgow. He received formal training in statistics (BSc Statistics, Chinese University of Hong Kong) and epidemiology (PhD, University of Hong Kong). He has extensive experience working with complex big data, including the Scottish and English primary care, hospital, and death records, national health surveys, and the UK Biobank. His research attempts to uncover the neglected complexity in exposure-outcome associations, such as their nonlinearity, mechanisms, and interactions. He has been the referee for top funders and journals, such as the British Heart Foundation, World Cancer Research Fund, Swiss National Science Foundation, the Lancet, and BMJ. Webpage.

Costan Magnussen, PhD, Baker Heart and Diabetes Institute, Australia
orcid.org/0000-0002-6238-5730
Research interests: Atherosclerosis, obesity, lipids, blood pressure, chronic disease epidemiology, early-life determinants of cardiovascular and metabolic diseases, cardiometabolic conditions with paediatric origins
Dr. Costan Magnussen is a chronic disease epidemiologist and Associate Professor, specialising in the investigation of early-life determinants of cardiovascular and metabolic (cardiometabolic) diseases. Harnessing the power of long-term observational studies, randomised controlled trials, and biorepositories, Dr. Magnussen’s research has advanced our understanding of the development and progression of cardiometabolic conditions with paediatric origins. Currently serving as an Editorial Board Member at BMC Medicine and an Associate Editor at Annals of Medicine, Dr. Magnussen has also provided his expertise as a reviewer for over 50 journals. As a journal editor, he is committed to upholding research standards and cultivating an open and proactive environment for the exchange of ideas toward important discoveries. With a passion for nurturing the next generation of scientists, Dr. Magnussen is engaged with the professional development of early-career researchers, providing guidance and support to help them excel in their chosen fields. Webpage.

Giulio Francesco Romiti, MD, Sapienza - University of Rome, Italy
Giulio Francesco Romitiorcid.org/0000-0002-3788-8942
Research interests: Cardiovascular Diseases; Atrial Fibrillation; Epidemiology; Systematic Review

Dr. Giulio Francesco Romiti is a Medical Doctor from Rome, Italy, where he obtained his medical degree at Sapienza - University of Rome. His research activities and expertise are related to clinical research in the broad field of cardiovascular disease, with a particular focus on atrial fibrillation. His research interests also include evidence synthesis. He also serves as a peer reviewer for several medical journals. Webpage

Gaetano Santulli, MD, PhD, FAHA, Albert Einstein College of Medicine, USA
Gaetano Santulliorcid.org/0000-0001-7231-375X
Research interests: Coronary artery disease, hypertension, cardiometabolic, cardiac arrhythmia, biomarkers, cardiac remodelling, blood pressure

Gaetano Santulli, MD, PhD is currently working at Albert Einstein College of Medicine - Montefiore University Hospital. A physician-scientist, he received his MD and PhD at the University of Naples “Federico II”. He completed his postdoctoral training at Columbia University Medical Center in New York City, fully supported by the American Heart Association (postdoctoral fellowship and Scientist Development Grant). Dr. Santulli’s expertise comprises both clinical – he is a cardiologist - and basic research topics, including hypertension, diabetes, heart failure, arrhythmias, vascular disease, microRNA, and mitochondrial pathophysiology. Webpage.

Alessandro Spirito, MD, Bern University Hospital, Switzerland
Alessandro Spirito picorcid.org/0000-0002-7473-6577
Research interests: Atherosclerosis, percutaneous coronary intervention, coronary arterty bypass grafting, coronary artery disease, ischemic heart disease, antiplatelet therapy, oral anticoagulation

Alessandro Spirito, MD is currently working at Bern University Hospital, Bern, Switzerland. He received his MD at the University of Genoa, Italy. He completed his postdoctoral training in Internal Medicine and Cardiology at Bern University Hospital, Switzerland. He spent 2 years as research fellow in interventional cardiology at Icahn School of Medicine at Mount Sinai Hospital, New York, fully supported by the Swiss National Science Foundation. Dr. Spirito’s clinical activity comprises general and interventional cardiology and his research expertise focuses on ischemic heart disease, percutaneous coronary intervention and antiplatelet therapy. Webpage.

Xiaoqiang Tang, PhD, Sichuan University, China
Xiaoqiang Tangorcid.org/0000-0003-1314-3417
Research interests: Cardiovascular biology Heart Failure, Cardiac Remodeling, Ischemia, Vascular Biology, Aging, Metabolism, Epigenetics, Fibrosis, cardiac hypertrophy, cellular senescence

Dr. Xiaoqiang Tang received his Ph.D. degree at Peking Union Medical College, where he studied cardiac hypertrophy with his mentor Prof De-Pei Liu. In 2017, Dr. Tang joined West China Second University Hospital of Sichuan University and he is currently an Associate Professor and Hundred Person Project Scholar. Dr. Tang is also the Associate Editor of Frontiers in Cardiovascular Medicine, Frontiers in Endocrinology, Frontiers in Cell and Developmental Biology, Editorial Board of Heliyon and BMC Cardiovascular Medicine, and TRAging. He has been the reviewer of over 30 peer-reviewed journals, including Signal Transduction and Targeted Therapy, Acta Pharmaceutica Sinica B, Clinical Science, Aging and Disease. Dr. Tang focuses on the pathology of cardiovascular diseases, including heart failure, cardiac hypertrophy, and vascular diseases. Especially, Dr.Tang studied epigenetics, metabolism, and niche mechanisms underlying cardiovascular aging and diseases. He is the author or co-author of many scientific articles, including Circulation, European Heart Journal, Science Translational Medicine, Circulation Research, Journal of Experimental Medicine, and Signal Transduction and Targeted Therapy. His articles have received over 2000 citations. Webpage. 

Guo-Wei Tu, MD, Zhongshan Hospital, Fudan University, China
Guo-Wei Tuorcid.org/0000-0001-7861-7631
Research interests: ICU, Mechanical Ventilation, Respiratory Physiology, Critical Care Medicine, Intensive Care Medicine, Sepsis, Hemodynamics

Dr. Guo-Wei Tu received his MD Degree in Medicine at Fudan University, China. He is the Professor of cardiac surgery intensive care unit of Zhongshan Hospital, Fudan University, China. In 2016, he was awarded with the Chinese Young Investigator Award for the research in critical care medicine. Dr Tu was awarded as Excellent Academic Leader of Shanghai and Top Young Talent of Shanghai in 2020. He has published more than 60 articles (first or corresponding author) in SCI-indexed journals and serves as guest editor and editorial board member of many scientific journals including Annals of Translational Medicine, BMC Cardiovascular Disorders, Cardiology Research and Practice et al. Webpage.

Hideki Uosaki, MD, PhD, Jichi Medical University, Japan
orcid.org/0000-0002-8964-8609
Research interests: iPS cell-derived cardiomyocytes, cardiomyopathy disease modeling, gene therapy, genome editing, transcriptome analysis, cardiomyocyte physiology, mitochondrial function
Hideki Uosaki, M.D., Ph.D. is an Associate Professor at Jichi Medical University. He joined the Center for Molecular Medicine at Jichi Medical University, after completing postdoctoral training in heart development and cardiology at Johns Hopkins University School of Medicine (2016). He earned his M.D. and Ph.D. from Hokkaido University (2004) and Kyoto University (2011), respectively. He is primarily focusing on deciphering the molecular mechanisms and finding treatment for cardiomyopathy. His research includes 1) iPS cell-based disease models, 2) animal models created with genome editing, 3) gene therapy (adeno-associated virus), and 4) transcriptome analysis. Webpage.

Bo Xi, MD, Shandong University, China
Bo Xiorcid.org/0000-0003-0491-5585
Research interests: Obesity, Hypertension, Cardiovascular disease, Lifestlyle, Tobacco, Children, Women

Dr. Bo Xi is a professor at the School of Public Health, Cheeloo College of Medicine, Shandong University. He is the director of Children Cardiovascular Research Center of Shandong University. He is the winner of National Science Foundation for Outstanding Youth in 2017 and the winner of the 15th China Youth Science and Technology Award in 2018. His research mainly focuses on epidemiology of childhood obesity, hypertension and cardiovascular risk factors. He has presided over 5 national projects. He has published over 50 English papers, including papers on BMJ, Circulation, JACC, Diabetes Care and Lancet Global Health. Dr. Bo Xi currently serves as the member of the National Expert Committee on cardiovascular diseases, the member of Chinese Preventive Medicine Association-Childhood Chronic Disease Prevention and Management, the youth member of the Epidemiology Branch of the Chinese Preventive Medicine Association, and the corresponding editor of the Chinese Journal of Epidemiology. Dr. Xi is also the peer reviewer of several international top journals including BMJ, Ann Intern Med, JACC, and Lancet Public Health. Webpage.

Junjie Xiao, PhD, Shanghai University, China
Junjie XIAOorcid.org/0000-0002-9202-0003
Research interests: Cardiovascular diseases; Heart failure; Cardiac Hypertrophy; Myocardial infarction; Exercise training; Biomarker; Extracellular vesicles; Non-coding RNAs

Junjie Xiao is currently a Professor at Shanghai University. He is the Vice Dean of Medical School and also the Vice Dean of School of Life Science at Shanghai University. He obtained the National Science Foundation for Outstanding Youth in 2017. He is also the Associate Editor of Journal of Cardiovascular Translational Research, Editorial Board of Journal of Sport and Health Science, Social Media Editor of Journal of Molecular and Cellular Cardiology, etc. He is the author or co-author of many scientific articles, including Circulation, Circulation Research, Cell Metabolism, Nature Communications, Annual Review of Genomics and Human Genetics, and BMC Medicine. He has been the reviewer of Physiological Reviews, Circulation Research, Cell Reports Medicine, Hypertension, Journal of the American College of Cardiology, Molecular Therapy, etc. He obtained 2018 and 2019 Peer Review Awards (Top 1% in Field, Publons). His major research interest is heart failure and exercise training, especially using exercise as a platform to identify novel targets for enhancing cardiac regeneration and combating cardiovascular diseases. Webpage.

Shiu Lun Ryan Au Yeung, PhD, The University of Hong Kong, Hong Kong
Ryan Au Yeungorcid.org/0000-0001-6136-1836
Research interests: Cardiovascular diseases, Type 2 diabetes, Mendelian randomization, alcohol, epidemiology

Ryan Au Yeung (MPH (HKU), PhD (HKU)) is currently an Assistant Professor at the School of Public Health, LKS Faculty of Medicine, The University of Hong Kong. He is interested in the use of Mendelian randomization to identify causes and consequences of cardiovascular diseases and type 2 diabetes, and to explore drug reposition opportunities. His earlier research focused on exploring the causal role of alcohol in cardiovascular diseases and mental health using ALDH2 polymorphism in a Southern Chinese Biobank (Guangzhou Biobank Cohort Study). His recent work involves the use of UK Biobank and summary statistics from genome wide association studies to explore pleiotropic effects of commonly prescribed medications in cardiovascular diseases and diabetes (e.g. metformin). With the COVID-19 pandemic, he is also using Mendelian randomization to explore determinants (e.g. glycaemic traits) contributing to COVID-19 susceptibility. Ryan Au Yeung is currently one of the academic leads of the “Children of 1997” birth cohort in Hong Kong, where he is responsible for curating the genomic and metabolomic data. Webpage

Hongsong Zhang, PhD, Nanjing Medical University, China
Hongsong Zhangorcid.org/0000-0003-4251-7609
Research interests: Atherosclerosis, vascular calcification, heart failure, endothelial function, coronary artery disease, vascular biology, cardio-metabolomics, CVD epigenetics

Dr. Hongsong Zhang obtained his PhD degree from The Chinese University of Hong Kong. His research interests focus on endothelial function in atherosclerosis, vascular calcification and diabetes. At present, he has published SCI-indexed articles as the first or corresponding author in top journals including Circulation Research, Cardiovascular Research and American Journal of Human Genetics. He has presided multiple projects including the National Natural Science Foundation of China. He is currently the academic member of Chinese Association of Pathophysiology. He was awarded Paul Dudley White International Scholar by American Heart Association (AHA). Dr. Hongsong Zhang is currently the Junior Editor Board Member of Aging and Disease, Journal of Genetics and Genomics and Journal of Translational Internal Medicine, Guest Editor of Journal of Clinical Medicine and Frontiers in Genetics, as well as the reviewer of many SCI-indexed journals including Canadian Journal of Cardiology, Frontiers in Cardiovascular Medicine and Journal of General Internal Medicine. Webpage.

Jie Jane Zhao, PhD, The University of Hong Kong, Hong Kong
Jie Jane Zhao headshotorcid.org/0000-0002-1564-0057
Research interests: nutrition; antihypertensive drugs; Mendelian randomization; non-communicable chronic diseases

With trainings in medical science, nutrition and epidemiology, my broad research interest is to understand the aetiology of non-communicable chronic diseases, as well as identifying modifiable targets for prevention and treatment of chronic diseases. I have been interested in the effect of endocrine factors in chronic diseases, such as the role of sex hormone binding globulin and testosterone in chronic kidney disease (published in JASN 2021 and BMC Medicine 2020, the latter selected as featured article of that issue). I’m also working on the role of dietary factors and medications, such as antihypertensive drugs, as potential targets for prevention and treatment of chronic diseases, with 50 publications in area-leading journals such as American Journal of Clinical Nutrition, BMC Medicine, BMJ, Diabetologia, and Annals of the Rheumatic Diseases.
In my research, I applied several study designs, including randomized controlled trial, cohort studies, as well as Mendelian randomization which uses genetic variants as instruments to minimize confounding. I also chaired a randomized controlled trial to assess the effects of intervention and the underlying mechanisms. I’m always open to collaborations in projects relevant to public health and clinical practice, and would like to serve the scientific community. Currently, I’m reviewer for Nature Ageing, BMJ, Diabetes Care, BMC Medicine, International Journal of Epidemiology, JAHA, British Journal of Cancer, Kidney International et al. Webpage. 
 

Endocrinology and Metabolism

Ling-Wei Chen, PhD, National Taiwan University, Taiwan
Ling-Wei Chenorcid.org/0000-0002-2661-8752
Research interests: Nutritional epidemiology, diet, dietary pattern, chrono-nutrition, DOHaD

Dr. Ling-Wei Chen is a nutritional epidemiologist with a keen interest in the Developmental Origins of Health and Diseases (DOHaD). He earned his PhD degree from the Saw Swee Hock School of Public Health, National University of Singapore (NUS; Singapore) and has held postdoctoral research positions at several institutions including the NUS School of Medicine, University College Dublin (UCD; Ireland), and Agency for Science, Technology and Research (A*STAR; Singapore). Currently, he holds an Assistant Professorship at the Master of Public Health Program and the Institute of Preventive Medicine and Epidemiology at National Taiwan University College of Public Health (Taiwan). Dr. Chen has published extensively in top international journals such as BMC Medicine, PLOS Medicine, and The American Journal of Clinical Nutrition. He is also a respected referee for academic journals and funding agencies, including the Medical Research Council (MRC; UK), Foundation for Science and Technology (FCT; Portugal), and Austrian Science Fund (FWF; Austria). Dr. Chen's contributions to the field of nutritional epidemiology and DOHaD have been recognized through various travel awards at prominent international conferences, such as the Early Career Travel Grants in conjunction with the 22nd IUNS International Congress of Nutrition and the DOHaD Society Travel Awards in conjunction with the 11th DOHaD World Congress. Webpage.

Huaidong Du, PhD, University of Oxford, UK
Huaidong Duorcid.org/0000-0002-9814-0049
Research interests: Nutritional Epidemiology, cardiometabolic disease prevention, eye disease epidemiology, Biobank study, prospective cohort study

Huaidong Du obtained a Medical degree in Clinical Medicine and MSc in Ophthalmology from China, where she had been practicing as an Ophthalmologist for several years before she moved to the West. She joined University of Oxford in 2010 after completing her MSc and PhD in Nutritional Epidemiology from the Netherlands. Currently, she is an Associate Professor in Nutritional Epidemiology working on the China Kadoorie Biobank (CKB) study, which is large prospective cohort study involving over 0.5 million Chinese adults recruited from 10 different Provinces. Her main research interests focus on lifestyle factors (e.g. diet, physical activity and adiposity) in aetiology of major chronic diseases, and vision and eye-related diseases. She also coordinate periodic CKB resurveys which are conducted every 5-6 years among ~25,000 randomly selected surviving participants. Webpage

Yuanqing Fu, PhD, Westlake University, China
Yuqing Fuorcid.org/0000-0002-3955-9376
Research interests: Precision nutrition, gut microbiome, nutritional epidemiology, public health nutrition

Yuanqing Fu is a research associate professor at Westlake University. He obtained his Ph.D. degree in nutrition from Zhejiang University in 2015. His research mainly focuses on investigating the interactions between diet, gut microbiome, and host genetics in the development of metabolic disorders such as dyslipidemia, cancer, obesity, and type 2 diabetes. To explore these relationships, he employs data derived from multiple omics disciplines, including genomics, proteomics, metabolomics, and metagenomics. Additionally, he is also interested in developing experimental designs for precision nutrition, such as n-of-1 trials, and elucidating the involvement of gut microbiome in achieving personalized nutritional interventions. He is now involved in several prospective cohort studies to understand the role of nutrients, dietary pattern, lifestyle factors and gut microbiome on risk of metabolic disorders, the effect of parental nutrition on offspring health, as well as the impact of early-life exposures on gut microbiome and long-term health issues. He serves as a committee member of the Nutrition and Health Food Division, the Public Health Nutrition Division of the Chinese Nutrition Society. Webpage.

Raúl González-Domínguez, PhD, Instituto de Investigación e Innovación Biomédica de Cádiz, Spain
Raúl González-Domínguezorcid.org/0000-0002-7640-8833
Research interests: Metabolomics, nutrition, gut microbiota, exposome, Alzheimer's disease, cognitive decline

Dr. González-Dominguez (PhD in Chemistry) is the Principal Investigator of the research group “Metabolomics & Bioanalysis”, located at “Instituto de Investigación e Innovación Biomédica de Cádiz” (INiBICA, Spain). His research lines are mainly focused on the development, application, and integration of mass spectrometry-based omics approaches, including metabolomics and metallomics, in biomedicine, nutrition, and food science. He has contributed to the development of bioanalytical key methods used for characterizing the role of the gut microbiota, nutrition, and other sources of exposure (i.e., the exposome) in health status, and to study inter-individual variability factors in the context of precision medicine. Using these omics approaches, Dr. González-Domínguez has great experience in investigating the molecular mechanisms behind the onset and progression of Alzheimer’s disease and cognitive decline, obesity and other cardiometabolic diseases. Webpage.

Jiaqi Huang, PhD, Central South University, China
Jiaqi Huangorcid.org/0000-0002-7808-9477
Research interests: Precision nutrition, nutritional epidemiology, metabolomics, metabolic epidemiology, chronic diseases, biostatistics

Jiaqi Huang, Ph.D., is a professor at National Clinical Research Center for Metabolic Diseases, and a joint professor at Xiangya School of Public Health, Central South University. She received her PhD degree in Medical Epidemiology from Karolinska Institute, Stockholm, Sweden; and she subsequently worked a post-doctoral fellow at the Division of Cancer Epidemiology and Genetics at the National Cancer Institute, United State. Her research expertise includes precision nutrition and preventive medicine, and her research experience has enabled applying rigorous study design and comprehensive statistical analytic skillset, as well as implementing state-of-the-science technologies through cutting-edge epidemiologic research projects within various data sources from large-scale studies. She has published original research articles in top tier journals, including JAMA Internal Medicine, Circulation, Circulation Research, Nature Communications, JNCI, and etc. Webpage.

Jingjing Jiao, PhD, Zhejiang Medical University, China
Jingjing Jiaoorcid.org/0000-0003-4167-1567
Research interests: Nutrition and disease, precise nutrition, nutritional epidemiology, cardiovascular metabolic disease, type 2 diabetes, public health nutrition

Jingjing Jiao, Ph.D., is a professor at Zhejiang University School of Medicine in Hangzhou, China within the Department of Nutrition at School of Public Health. She is a joint professor at the Department of Endocrinology of the Second Affiliated Hospital of Zhejiang University School of Medicine. She is also a visiting professor at Harvard University T H Chan School of Public Health. Her research expertise includes precise nutrition and preventive medicine with a special interest in nutrition (including nutrients, diets and dietary patterns) and the prevention and control of chronic diseases especially cardiovascular metabolic diseases. Her research also focuses on the relationship between polyunsaturated fatty acids (PUFA), especially long-chain n-3 PUFA, and cardiovascular metabolic diseases and the mechanism of regulating glycolipid metabolism. She has published original research papers in top peer-reviewed journals such as BMJ-British Medical Journal, Circulation Research, Diabetes Care, Journal of Internal Medicine, Chemical Reviews, Microbiome, etc. She serves as a committee member of the Nutrition and Health Food Division, the Nutrition and Omics Technology Division, the Nutrition Big Data and Health Division of the Chinese Nutrition Society, and the Sports and Public Health Division of the Chinese Biophysics Society. Webpage.

Lee-Ling Lim, MBBS, PhD, FRCP, University of Malaya, Malaysia
Lee-Ling Limorcid.org/0000-0002-6214-6924
Research interests: Diabetes mellitus, cardiometabolic medicine, heart failure, diabetic kidney disease, integrated care, precision medicine, implementation science

Dr. Lim is a Senior Consultant Endocrinologist and Head of the Diabetes Care Unit, University of Malaya Medical Centre, Kuala Lumpur, Malaysia. As a clinician-scientist, Dr. Lim’s major areas of interest are cardiometabolic medicine with translational and implementation science components. She sits on the Scientific Work Groups of the ADA/EASD Precision Medicine in Diabetes Initiative, the WHO Global Diabetes Compact and The Lancet Commission on Diabetes, who provide authoritative resources in tackling the global diabetes epidemic. She has published ~80 peer-reviewed articles including high-impact journals such as The Lancet, Nature, Diabetes Care, and PLoS Medicine. Dr. Lim has received several awards including the World’s Top 2% Scientists 2022 by Stanford University and the EFSD Albert Renold Fellowship. Webpage.

Sartaj Ahmad Mir, PhD, National University of Singapore, Singapore
Sartaj Ahmad Mirorcid.org/0000-0001-6032-0936
Research interests: Lipidomics, metabolomics, metabolism, lipoproteins, fatty acids, maternal and child health, insulin resistance, diabetes

Sartaj Ahmad Mir, Ph.D. is a research scientist at the Singapore Lipidomics Incubator, Department of Biochemistry, National University of Singapore where his main focus has been on lipid and lipoprotein metabolism. He has developed and applied quantitative lipidomics methods for population-scale studies. Through extensive national and international collaborative efforts, he has been examining the role of plasma lipids in maternal and child outcomes in population-based birth cohorts. He has implemented methods for the characterization of baseline changes in circulating metabolites from preconception through pregnancy to postpartum as well as the lipid signatures of cardiometabolic health in childbearing women. He continues to develop the state-of-the-art mass spectrometry methods to elucidate the role of lipids in pregnancy and early childhood. Webpage.

Marloes Dekker Nitert, PhD, The University of Queensland, Australia
Marloes Dekkerorcid.org/0000-0002-1909-8920
Research interests: metabolic and cardiovascular complications of pregnancy and the role of the microbiome

Dr Marloes Dekker Nitert is a Senior Lecturer in Metabolism at The University of Queensland. She was educated in The Netherlands (MSc, University of Amsterdam), Sweden (PhD, Lund University) and the UK (PG Certificate Clinical Trials, LSHTM). Marloes' research focuses on metabolic and cardiovascular complications of pregnancy and the role of the microbiome in the development of these complications. She works closely together with clinician-scientists. The overall aim of her research is to improve outcomes for mothers and babies. Webpage.

Noah Peeri, PhD, Memorial Sloan-Kettering Cancer Center, USA
Noah Peeriorcid.org/0000-0003-4278-650X
Research interests: Epidemiology, health disparities, genetic epidemiology, nutritional epidemiology, cancer survivorship, cancer epidemiology

Dr. Peeri is a post-doctoral research scholar at Memorial Sloan-Kettering Cancer Center. He obtained his doctorate in epidemiology from the University of North Texas Health Science Center and his masters of public health in epidemiology from the University of South Florida. His research interests lie at the intersection of nutrition and genetics and their role in cancer etiology. He has training in advanced epidemiologic methods (i.e., causal inference), cancer epidemiology, and nutritional epidemiology. His research focuses on reducing cancer health disparities across several cancers. Webpage.

Catarina Schiborn, PhD, German Institute of Human Nutrition Potsdam-Rehbruecke, Germany
Catarina Schiborn picorcid.org/0000-0002-9556-4540
Research interests: Risk prediction, risk scores, type 2 diabetes, cardiovascular diseases, observational studies, population-based cohorts

Dr. Catarina Schiborn is a postdoctoral research fellow at the German Institute of Human Nutrition Potsdam-Rehbruecke, Germany. She earned her PhD in Epidemiology at the University of Potsdam and holds an MSc in Epidemiology from the Charité University Medicine Berlin, Germany, and an MSc in Nutrition Science from the Martin Luther University Halle-Wittenberg, Germany. Her research is dedicated to the different dimensions of cardiometabolic disease risk prediction. She is working on the identification of novel risk markers, the construction of clinical risk prediction models for individual absolute risk estimations and is interested in risk score implementation and impact assessment. Webpage.

Gabriela Telo, PhD, Pontifical Catholic University of Rio Grande do Sul, Brazil
Gabriela Heiden Telo Fayorcid.org/0000-0001-9093-383X
Research interests: Evidence-Based Practice; Type 1 Diabetes; Type 2 Diabetes; Obesity; Adherence; Mental Health; Cognitive Bias; Multiprofessional Care

Gabriela H. Telo is an endocrinologist and associate professor at the Pontifical Catholic University of Rio Grande do Sul (PUCRS) in Brazil. She completed her MSc and PhD degree, as well as her two years’ postdoctoral training in Endocrinology and Medical Sciences at the Federal University of Rio Grande do Sul (UFRGS). She was also a research fellow in diabetes at Joslin Diabetes Center/Harvard Medical School (2013-2015). Dr. Telo joined the School of Medicine at PUCRS in March 2019, creating and leading a National Council for Scientific and Technological Development (CNPq) research group focused on prevention, identification and multiprofessional care in diabetes. She has been the creator and teaching coordinator of the Interdisciplinary Diabetes League (LIDIA) at PUCRS, an interinstitutional league that brings together undergraduate and graduate students from two Brazilian universities (PUCRS and UFGRS) for the development of projects aimed at bringing improvements to the community with type 1 and type 2 diabetes. Webpage

Thaddäus Tönnies, DrPH, Leibniz Center for Diabetes Research at Heinrich Heine University, Germany
Thaddaus Tonniesorcid.org/0000-0003-1577-4212
Research interests: Diabetes Epidemiology, Epidemiologic Methods, Prevalence, Incidence, Years of Life Lost, Modelling, Projections

Dr. Thaddäus Tönnies is an epidemiologist and post-doctoral researcher at the German Diabetes Center in Düsseldorf, Germany. After completing his MSc in Epidemiology he received his PhD in Public Health in 2020 from the Faculty of Medicine at Heinrich Heine University Düsseldorf. His research focuses on descriptive epidemiology using aggregated data and projections of future disease and economic burden of diabetes with a special focus on socioeconomic inequalities. This includes the estimation and projection of future prevalence of diabetes and associated impacts on mortality, life expectancy and economic productivity. This work is often conducted in collaboration with national public health agencies. Further interests include the application of causal inference methods in observational research and social epidemiology. With his research, Dr. Tönnies aims to raise awareness for the future impact of the diabetes epidemic on population health. Webpage

Hongjiang Wu, PhD, The Chinese University of Hong Kong, Hong Kong
Hongjiang Wuorcid.org/0000-0003-2193-1114
Research interests: Diabetes, Epidemiology, Noncommunicable disease, Socioeconomic status, Trend analysis

Dr. Wu is an epidemiologist and a research assistant professor at the Chinese University of Hong Kong. He received this PhD degree in epidemiology at the University of Edinburgh in the UK, and completed two years’ postdoctoral training at the Chinese University of Hong Kong. Dr. Wu’s research interests focus on diabetes epidemiology, including population surveillance of diabetes, young-onset diabetes, and social determinants of diabetes. He has extensive experience in large cohort studies and analysis of routinely collected administrative data. Over the past several years, Dr. Wu has contributed importantly to establishing the territory-wide Hong Kong Diabetes Surveillance Database involving more than 4 million individuals. His research aims to improve the understanding of epidemiology of diabetes and gaps of diabetes care in Hong Kong. Webpage.

Ju-Sheng Zheng, PhD, Westlake University, China
Ju-Sheng Zhengorcid.org/0000-0001-6560-4890
Research interests: Nutrition epidemiology, type 2 diabetes, genetic epidemiology

Ju-Sheng got his PhD degree in nutrition at Zhejiang University, Hangzhou, China (2009-2014). Within his PhD program, he received one year’s training in the Nutrition and Genomics Lab at Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University in the USA (2012). He was also a Marie Skłodowska-Curie Individual Fellow supported by the European Commission and a postdoctoral researcher at the MRC Epidemiology Unit, University of Cambridge, UK (2015-2018). Ju-Sheng joined the School of Life Sciences at Westlake University as a Principal Investigator and group leader in September 2018 and has been leading the Laboratory of Human Nutrition and Epidemiology at Westlake University. Webpage
 

Gastroenterology
 

Ina Bergheim, PhD, University of Vienna, Austria
Ina Bergheimorcid.org/0000-0002-3356-4115
Research interests: Liver, nutrition, alcohol, endotoxin, intestinal barrier, obesity, aging

Dr. Ina Bergheim is a Full-Professor at University of Vienna, Department of Nutritional Sciences, RF Molecular Nutritional Science in Vienna, Austria. She is a Nutritional Scientist by training and obtained her PhD at the University of Hohenheim, Stuttgart, Hohenheim. After doing a PostDoc time at the University of Louisville, Kentucky, USA and habilitating at the University of Hohenheim, Stuttgart, Germany show was appointed as a Full-Professor at the Friedrich-Schiller University in Jena, Germany before joining the University of Vienna as a Full-Professor in 2016. Her main interest in research lays in the interaction of foods and beverages including alcohol with intestine and herein especially the intestinal barrier function as well as the liver as modulators of health and diseases. Webpage.

Huarong Chen, PhD, The Chinese University of Hong Kong, Hong Kong
Huarong Chenorcid.org/0000-0003-2192-1864
Research interests: Gastrointestinal cancer, cancer immunology, epitranscriptomicsm colorectal cancer, RNA modification, tumor immune microenvironment, cancer biology, cancer biomarkers, cancer diagnostics, targeted therapy for cancer, molecular oncology, signal transduction

Dr, Huarong Chen is currently a Research Assistant Professor in the Department of Anaesthesia and Intensive Care, and Principal Investigator in the State Key Laboratory of Digestive Disease of the Chinese University of Hong Kong. His primary research interests include basic and translational research of gastrointestinal cancer. He revealed abnormal genetic and epigenetic changes that contribute to the development of gastrointestinal cancer and elucidated their molecular mechanisms and potential clinical implications. Dr. Chen completed his Ph.D. study in Oncology with Prof. Shu Zheng at Zhejiang University and conducted his postdoctoral work at the Department of Medicine & Therapeutics of CUHK with Prof. Jun Yu. He has published over 60 articles in renowned journals such as Gastroenterology, Gut, Cell Rep Med, FEMS Microbiol Rev, EbioMedicine, Theranostics, and Oncogene. Recognized for his outstanding achievements, he was honored as an Emerging Leader in the field of oncology by Oncogene journal. Webpage.

Arunkumar Krishnan, MD, West Virginia University School of Medicine, USA
Arunkumar Krishnanorcid.org/0000-0002-9452-7377
Research interests: Obesity, Hepatobiliary diseases, metabolic syndrome, oncology, Nonalcoholic fatty liver disease, Cirrhosis, pharmacoepidemiology, and endoscopic bariatric and metabolic therapies. advanced endoscopy

Dr. Arunkumar Krishnan obtained his Degree in Medicine and residency in India. He is now working as an Advanced Endoscopy Clinical Research Fellow at West Virginia University School of Medicine, USA. He worked as a Clinical Research Fellow in the Division of Gastroenterology & Hepatology at Johns Hopkins University School of Medicine. Dr. Krishnan received several prestigious awards and travel grants for his research works, which include a prestigious Young Clinician Award from World Gastroenterology Organization and Young Investigator Award from the international Pancreatic Association. He is interested in an innovative, integrative, and critical-thinking approach to evidence-based clinical medicine. His primary research concerns Internal medicine, Gastroenterology, and hepatology. His research works often connect related areas like metabolic syndrome, cardiovascular diseases, oncology, and pharmacoepidemiology in his Internal medicine studies, in addition to integrating research after advanced therapeutic endoscopic procedures and endoscopic bariatric and metabolic therapies. He has published more than 60+ peer-reviewed papers in journals on diverse topics. Webpage.

Dabin Liu, PhD, Harbin Medical University, China
Dabin Liuorcid.org/0000-0002-3811-8317
Research interests: Non-alcoholic fatty liver disease, medicine, liver cancer, oncology, cholesterol metabolism, obesity, nutrition, disorders of adipocyte-liver interaction

Dr. Liu obtained his PhD degree in medicine at the Chinese University of Hong Kong in 2017, and completed three years’ postdoctoral training at the same university. He is now working as a professor at the NHC Key Laboratory of Molecular Probes and Targeted Diagnosis and Therapy, Harbin Medical University, China. Dr. Liu’s research interests focus on the pathogenesis, clinical diagnosis and treatment of non-alcoholic fatty liver disease (NAFLD) and NAFLD associated HCC (NAFLD-HCC). His work was selected as one of the spotlight achievements in NAFLD pathogenesis and treatment in 2018. His research aims to discover and identify novel driver genes and therapeutic strategy of NAFLD and NAFLD-HCC in China. Webpage.

Alexandre Nuzzo, MD, PhD, Beaujon Hospital, Paris Cité University, France
Alexandre Nuzzoorcid.org/0000-0002-8952-7620
Research interests: Gastroenterology and hepatology, enteral and parenteral nutrition, short bowel syndrome, abdominal pain, mesenteric ischemia, IBD (crohn’s disease and ulcerative colitis). Intensive care medicine, GI emergencies.

Alexandre Nuzzo, MD, PhD, is a consultant gastroenterologist and intensivist. He completed a MD in both Gastroenterology and Intensive Care Medicine, before getting a PhD in Biochemistry at Imperial College London and Paris Cité University. His clinical and research work in the Intestinal Stroke Center (Beaujon Hospital, Paris Cité University) focuses on improving knowledge and management of gastro-intestinal vascular and inflammatory bowel diseases. Webpage.

Andrea Shin, MD, University of California, Los Angeles, USA
Andrea Shinorcid.org/0000-0001-7284-3398
Research interests: disorders of gut-brain interaction, functional gastrointestinal disorders, irritable bowel syndrome, chronic constipation, dyssynergic defecation, gastroparesis, gastrointestinal motility disorders, functional diarrhea

Andrea Shin, M.D., is affiliated with University of California, Los Angeles. She received her medical degree from Indiana University School of Medicine and completed her internal medicine residency at Indiana University School of Medicine. She then earned a master’s degree in clinical and translational research while training as a research fellow under the mentorship of Michael Camilleri, M.D., at Mayo Clinic in Rochester, Minnesota, followed by completion of a clinical fellowship in gastroenterology and hepatology at Indiana University. She is a member of several organizations including the American Gastroenterological Association (AGA), American College of Gastroenterology (ACG) and American Neurogastroenterology and Motility Society (ANMS). Prior to receiving her medical degree, she completed her undergraduate studies at Indiana University in Bloomington, Indiana earning a B.S. in biology and a B.A. in Spanish. She received the Arthur Metz scholarship for her undergraduate studies and was an honorary member of Phi Eta Sigma. Dr. Shin specializes in the care of patients with functional gastrointestinal and motility disorders. Her research focus relates to her clinical expertise and focuses on developing novel diagnostic and therapeutic approaches to treating functional gastrointestinal disorders such as irritable bowel syndrome (IBS). Specific research interests include study of the role of the microbiome, metabolome, diet and psychological distress in IBS, chronic constipation and functional diarrhea. She is a prior recipient of an institutional career-development award (KL2) and a current recipient of a K23 career development award through the National Institutes of health. Webpage.

Guoxiang Xie, MD, Human Metabolomics Institute, China
Guoxiang Xieorcid.org/0000-0002-0951-4150
Research interests: Metabolomics, biomarker discovery, gut microbial-host co-metabolism, metabolic disease biomarkers, gastrointestinal cancer, gastrointestinal carcinogenesis, bile acid metabolism

Dr. Guoxiang Xie is the vice president of the Human Metabolomics Institute (Guangdong, China) and an adjunct professor at Kunming University of Science and Technology, China. Previously, he has been an Assistant Professor of the University of Hawaii Cancer Center (a National Cancer Institute designated cancer center) (2013-2018). Dr. Xie also served as a research scientist in the Center for Translational Biomedical Research at the University of North Carolina at Greensboro for about 5 years. Dr. Xie received his M.D. degree in Pharmaceuticals from Shanghai Jiao Tong University, Shanghai, China. Dr. Xie has more than 20 years of experience as a scientist in bioanalytical science, metabolomics and in the medical field, and published over 100 peer-reviewed papers on metabolomics and biomedical research. He has worked on dozens of metabolomics projects that span the translational research spectrum from various rodent models to human clinical trials. Dr. Xie’s current research focuses on conducting comprehensive metabolomic studies to (1) identify the metabolite markers for disease diagnosis and stratification and (2) define the molecular mechanisms that link metabolic disruptions in gut microbial-host co-metabolism to metabolic disorders and gastrointestinal cancer. Webpage.

Santosh Yadav, PhD, University of Nebraska Medical Center, USA
Santosh Yadav picorcid.org/0000-0001-9728-4561
Research interests: Gut microbiome and dysbiosis, pancreatitis, IBD and colon cancer, barrier proteins, PTSD, oxidative stress and Inflammation, cardiovascular disease, diabetes cardiomyopathy, inflammatory and non-inflammatory cell death mechanisms

Dr. Santosh Kumar Yadav (Ph.D), earned his degree from the National Institute of Immunology, New Delhi, India. Dr. Yadav is currently working as a research instructor in the Department of Biochemistry and Molecular Biology at the University of Nebraska Medical Center (UNMC). As an instructor, he is involved in understanding the pathophysiology of gut-related inflammatory diseases, including IBD and colon cancer, as well as post-traumatic stress disorder (PTSD), gut dysbiosis, and pancreatitis. Dr. Yadav delineates the role of barrier proteins in gut inflammation, gut dysbiosis, and their connection with the brain via the gut-brain axis using the repeated social defeat stress (RSDS) model. Along with the PTSD project, Dr. Yadav is also involved in understanding the role of barrier proteins in the pathophysiology of acute and chronic pancreatitis. Dr. Yadav’s previous research at UNMC was to understand the role of oxidative stress and inflammation in the pathophysiology of cardiovascular disease, including diabetes and obesity-induced cardiomyopathy, as well as cardiac stem cell physiology. Particularly, he was involved in delineating the role of inflammatory (pyroptosis/necroptosis) and apoptotic cell death mechanisms in the pathology of hyperglycemia/diabetes-mediated cardiac cell death and heart failure. Overall, Dr. Yadav’s research focuses on developing a therapeutic target for inflammatory mucosal and cardiovascular disease. Webpage.

Xiaotao Zhang, PhD, Icahn School of Medicine at Mount Sinai, USA
Xiaotao Zhangorcid.org/0000-0002-3968-5030
Research interests: Microbiome, epidemiology, nutrition, cancer epidemiology, liver disease, gastrointestinal disease, cancer prevention, clinical trial

Dr. Xiaotao Zhang, is an assistant professor at Icahn school of medicine at Mount Sinai. Dr. Xiaotao Zhang earned his medical degree in Preventive Medicine in China. With a growing interest in disease prevention at the level of population health, he emigrated to the U.S to continue his education and training in Biostatistics and Epidemiology at Tulane University in New Orleans and The University of Texas Health Science Center in Houston. By merging epidemiologic methods with innovative techniques and bioinformatic/statistical strategies, his current research examines the role of biological and modifiable factors in cancer disparities and cancer prevention. He hopes to unravel risk factors and mechanisms to inform the development of new preventive interventions and clinical strategies. Webpage.
 

Geriatric Medicine
 

Prasad Nishtala, PhD, University of Bath, UK
orcid.org/0000-0002-4155-8540
Research interests: Pharamcoepidemiology, geriatrics, polypharmacy, deprescribing
Prasad NishtalaI have a multidisciplinary background in pharmacy, epidemiology, and data science, and expertise in outcome-based health informatics and pharmacoepidemiology. My overarching research purpose is to develop a coordinated approach to accelerate real-world evidence using Big data to improve ageing and pioneer translational research to improve the safety of medicines in the ageing population. Webpage.



Yao Yao, MD, Peking University, China
Yao Yao picorcid.org/0000-0002-6723-6152
Research interests: Healthy aging, fall prevention, compression of dependency, health management, cohort study

Yao Yao holds an M.D. from the Chinese PLA General Hospital and has undergone three years of training in Geriatrics. After completing the postdoctoral research at both Peking University and Duke University, Yao joined the China Center for Health Development Studies at Peking University as an Associate Professor. Yao Yao's research interests include F4 (Fight for Falls, Fractures, and Functioning disability) and "Compression of Dependency". Being a key investigator in the Chinese Longitudinal Healthy Longevity Study (CLHLS), Yao is also key commissioners for two Lancet commissions "The path to healthy ageing in China: a Peking University-Lancet Commission" and "The Lancet standing commission on dementia prevention, intervention and care 2024." Webpage.
 

Global, Public and Environmental Health
 

Loai Albarqouni, MD, MSc, PhD, Bond University, Australia
Loai Albarqouni picorcid.org/0000-0002-4114-9106
Research interests: Evidence-Based Practice; Primary Care; Low value care; Overdiagnosis; Non-communicable Diseases; Clinical Epidemiology

Loai is a Postdoctoral Research Fellow at the Institute for Evidence-Based Healthcare. His research expertise includes evidence synthesis, evidence-based practice, healthcare services, and primary care. He is a medical doctor (MD) from Palestine and completed a Master’s degree in clinical epidemiology at Ludwig Maximilian University of Munich in Germany, followed by a PhD degree in evidence-based practice from Bond University, Australia. Webpage.

Steven Bell, PhD, University of Cambridge, UK
StevenBellpicorcid.org/0000-0001-6774-3149
Research interests: Alcohol; coronary heart disease; stroke; small vessel disease; Mendelian randomization; GWAS

Steven is an Epidemiologist based within the Stroke Research Group at the University of Cambridge with an interest in cardiovascular disease and related conditions.
His work utilises genome-wide association studies (GWAS) alongside bioinformatic approaches to obtain insights in disease aetiology. This includes applying techniques such as Mendelian randomization to prioritise therapeutic targets and inform clinical or public health decision making.
More widely, he has an interest in individual participant data meta-analysis, the use of electronic health records in medical research, the application and integration of various “-omic” technologies (e.g. metabolomics, proteomics, phenomics), machine learning and modelling of longitudinal data. Webpage.

Jean Joel Bigna, MD, Centre Pasteur of Cameroon, Cameroon
Jean Joel R Bignaorcid.org/0000-0001-8018-6279
Research interests: Epidemiology, Systematic reviews, Meta-analysis, Clinical Trials, Metabolic syndrome, Diabetes, Hypertension, Cardiovascular risk factors, Dyslipidemias, Obesity, Pulmonary Hypertension, HIV, hepatitis, Tuberculosis, Public Health, Global Health

Jean Joel is a medical doctor and researcher from Cameroon. It is an expert in epidemiology, clinical trials, and systematic reviews with focus on infectious diseases and non-communicable diseases and the interplay between these two conditions in the global context. He authored more than a hundred of papers in high-impact peer-reviewed journals. In his free time, Jean Joel spends a lot of time with his family playing video games and basketball. Webpage.

Emelda Okiro, PhD, KEMRI Wellcome Trust Research Programme, Kenya
eokiro _ Kemri _ Wellcome Trustorcid.org/0000-0001-9543-8360
Research interests: Global Health, Malaria, RSV, Child Health, Childhood Immunization, Health Access, Population health

Emelda heads the Population Health Unit within the KEMRI-Wellcome Trust Research Programme in Kenya which aims to understand determinants of health transitions and vulnerabilities at fine scales across Africa and works to embed the use of data for decision-making by national ministries. Emelda has 20 years of Population and Public Health research experience. Deep expertise in Impact evaluation, epidemiology, public health, statistics, data analytics and operations research with a focus on evaluations and contribution analysis. Prior to this position Emelda was a Program Officer/Gates Fellow within the Global Health Team at the Bill and Melinda Gates foundation. She has worked on evaluating the public health impact of malaria control, on evaluating anti-retroviral treatment programs while at IHME and on developing strategies for primary health care at Philips Research Africa. Emelda has a PhD in Epidemiology, has been awarded two internationally competitive Wellcome Trust (UK) Fellowships and is widely published. Webpage.

Petteri Oura, MD, PhD, University of Helsinki, Finland
Petteri Oura (1)orcid.org/0000-0001-5637-3971
Research interests: Public health, life course epidemiology, causes of death, forensic medicine

Petteri obtained his MD-PhD degree at the University of Oulu, Finland. Since his PhD dissertation in 2017, Petteri has undertaken several research projects in the fields of life course epidemiology, public health, and forensic medicine. Petteri currently serves as a resident forensic pathologist in a joint position between the University of Helsinki and Finnish Institute for Health and Welfare, where he also leads the Finnish Translational Forensic Neuropathology research group. Webpage.

Carmen Piernas, PhD, University of Granada, Spain
Carmen Piernas picorcid.org/0000-0002-7536-922X
Research interests: nutritional epidemiology, dietary interventions, NCD prevention

Dr Piernas is a Nutrition scientist, currently working as a Ramon y Cajal fellow at the University of Granada (Spain) as well as honorary University Research Lecturer at the University of Oxford (UK) since 2015. She graduated with a PhD in Nutrition and Epidemiology from the University of North Carolina at Chapel Hill (USA). She is currently working on healthy and sustainable dietary interventions for the prevention of cardiometabolic diseases. Her research is grounded within the Precision Nutrition field and focuses on the integration of nutritional and lifestyle factors with omics data (from biological samples and microbiome data) to improve the understanding and prevention of noncommunicable diseases. Webpage.

Zhirong Yang, PhD, University of Cambridge, UK
Yang-ZhirongResearch interests: diabetes, hyperlipidemia, dementia, stroke, atherosclerosis, acne, primary care, routine healthcare data, pharmacoepidemiology, systematic review and meta-analysis

Zhirong completed a PhD in the Department of Public Health and Primary Care at University of Cambridge. He also holds a bachelor's degree in medicine and master's degrees in epidemiology and in primary care research. He was a research fellow in the Department of Population Medicine at Harvard University in 2018. Before his PhD, he worked as a biostatistician in Shantou-Oxford Clinical Research Unit and then as a research associate in Peking University School of Public Health. His current research interests are in the use of routine healthcare data and evidence synthesis to inform the management of cardiovascular diseases, dementia and diabetes. Webpage.

Zhenyu Zhang, PhD, Peking University, China
Zhenyu Zhangorcid.org/0000-0002-3327-8637
Research interests: Environmental Epidemiology; Cardiovascular diseases; cohort study; Air pollution; Public Health; Global Health, climate change, respiratory infection

I am a start-career investigator in the field of environmental epidemiology and global health. My interdisciplinary research lies in global climate change, air pollution, exposure estimation modeling, global infectious diseases, global health, and general epidemiology. My interests are: (1). Evaluating the effects of climate change on infectious diseases. I combine methods from traditional epidemiology, atmospheric science, and statistical modeling with the aim of answering questions of relevance to patients and policymakers. (2). Environmental epidemiology, especially particulate matter, we used comprehensive statistical models to estimate the individual PM air pollution exposure for participants from different cohorts from China, US, and South Korea, we also evaluated the health effects of PM on cardiovascular, otolaryngologic diseases, and cancer in cohort studies. (3). Translational epidemiology: I have a great interest in creating modeling frameworks that allow decision-makers to translate epidemiological data into effective decisions. I welcome collaboration from researchers, clinicians, or students having expertise in any field, who hope to create models to translate epidemiological data into meaningful policy, practical, or clinical decisions.


Health Services Research

Mohamed Estai, PhD, The University of Western Australia, Australia
orcid.org/0000-0001-7109-0267
Research interests: Health services research, RCTs, systematic review, diagnostic accuracy, surveys, population health, e-health, epidemiology, digital health, qualitative research, disease screening, prevention, artificial intelligence, rural and remote health, user behaviour, dental public health, global health, social determinants, health promotion
I hold a PhD degree from the University of Western Australia (2018). I have over 10 years of experience in research, writing, and academic publishing. My research background lies in digital health and population health. I have been working with researchers from the USA, Singapore, Thailand and Saudi Arabia on different projects. I have a good track record in funding and publication. I secured over $500,000 in research funding over the past 4 years. Throughout my career, I have actively engaged with the scholarly community as both an author and an editor. With over 40 research papers published in reputable journals, I have gained invaluable firsthand knowledge of the publication process. Additionally, I have served as a reviewer for numerous journals, honing my attention to detail and comprehensive understanding of academic standards. My editorial contributions extend to prestigious journals such as BMC Public Health (Q2) and Scientific Reports (Q2), where I serve on the editorial board. Currently, I hold the position of Research Program Officer at Western Australia Country Health Services (WACHS) since November 2022. I also maintain the role of Honorary Research Fellow at the University of Western Australia since 2019. I am a member of the HREC at the North Metropolitan Health Services, Graylands Hospital. Webpage.

Yixue Shao, PhD, Centers for Disease Control and Prevention, USA
orcid.org/0000-0003-1410-5455
Research interests: Health economics and outcomes research, health policy, health services research, endocrinology and metabolism
Yixue ShaoDr. Yixue Shao is a Prevention Effectiveness Fellow at the Centers for Disease Control and Prevention, working within the National Center for Chronic Disease Prevention and Health Promotion-Division of Diabetes Translation. She obtained her PhD in Health Policy and Management and her MPH in Health Systems Management from Tulane University. Her research interests include health services research, health policy, and health economics and outcomes research, specifically related to diabetes. She has published original research papers in top peer-reviewed journals such as JAMA Network Open, Value in Health, Diabetes, Obesity and Metabolism, and Medical Care, among others. Webpage.

Jason Wasiak, PhD, Monash University, Australia
Jason Wasiakorcid.org/0000-0002-5194-1586
Research interests: clinical expertise (burns, plastics, intensive care); clinical epidemiology; evidence-based medicine; evidence synthesis; randomised and non-randomised studies; medical writing; retracted publications.

Jason has worked as a clinician, clinical researcher, systematic reviewer and medical writer in diverse clinical and non-clinical settings. Tertiary qualifications cover adult education, critical care, epidemiology/biostatistics and public health. His research career has focused on working with health care professionals to improve the health of patients through decisions underpinned by reliable evidence-research synthesis. Work experience has concentrated on evaluating acute care practices in the clinical setting, identifying ways to deliver high-quality care through health services research and teaching evidence-based healthcare. His research expertise includes evidence synthesis, pragmatic clinical research, writing for publication, and research and publication ethics. Webpage
 

Infectious Diseases
 

Samuel Akech, PhD, KEMRI-CGMRC/Wellcome Trust, Kenya
Sam Akech 20210616_192334orcid.org/0000-0001-5126-1225 
Research interests: malaria, sepsis, antimicrobial resistance, paediatrics, quality of care, dehydration, malnutrition

Sam (MBChB, MMED (Paediatrics), Dphil) is a principal investigator at the KEMRI/Wellcome Trust Programme, Nairobi, a honorary lecturer at the Department of Paediatrics, University of Nairobi, Kenya, and a Visiting Research Fellow, University of Oxford, United Kingdom. He is a consultant paediatrician and clinical epidemiologist with research interest in severe febrile illnesses in children. His research spans understanding epidemiology of severe febrile illnesses in children, clinical trials, investigation of effectiveness of treatments in children admitted with severe illnesses, antimicrobial resistance, application of machine learning techniques and data science for biomedical clinical data, and in design of appropriate digital solutions for identification and management of paediatric sepsis. He runs an inpatient surveillance to answer questions of safety following introduction of new interventions, such a recently introduced malaria vaccine in Kenya, and to understand how compliance with clinical guidelines affect in-hospital survival. He is involved in teaching and supervision of postgraduate and doctorate students, is a peer reviewer for several medical journals and research funders and provides technical consultation to global bodies involved in health such as the World Health Organization (WHO). Webpage.

Andrei R. Akhmetzhanov, PhD, National Taiwan University, Taiwan
Andrei Akhmetzhanovorcid.org/0000-0003-3269-7351
Research interests: modeling, infectious diseases, outbreaks, COVID-19, Bayesian, infection control, reproduction number, emerging infectious diseases, vaccines, public health, global health

Andrei R. Akhmetzhanov graduated from Moscow Institute of Physics and Technology, Russia and decided to pursuit his academic career in theoretical epidemiology and public health. With background in applied mathematics and physics, he found himself lucky to work with many profound scholars in biology, medicine, and computer sciences. He trained himself to deal with more applicable research involving data analysis and statistical inference. His expertise lies in mathematical modeling of infectious diseases with particular interest on outbreak investigation and identification of epidemiological parameters for emergent infectious diseases. In the past ten years, he lived in four different countries (Canada, France, Japan, Taiwan), and finally resided in Taiwan. Currently he is an assistant professor in Global Health Program and Institute of Preventive Medicine and Epidemiology at National Taiwan University College of Public Health in Taipei. While working in Japan, he was a volunteer member of the national COVID-19 task force in 2020. During 2021-2022, he interacted with Taiwan Centers for Diseases Control on similar matters. Webpage.

Marion Brunck, PhD, Tecnológico de Monterrey, Mexico
Marion Brunckorcid.org/0000-0001-8994-8276
Research interests: Neutrophils, granulocyte transfusions, breastmilk, flow cytometry

I am currently an Associate Professor at Tecnológico de Monterrey, in Mexico. I completed my PhD in biotechnology at The University of Queensland and a postdoc in experimental hematology at the Translation Research Institute, both in Brisbane, Australia. There I studied ex vivo neutrophil production and hematopoietic stem cell mobilization, respectively. In Mexico, I applied my multidisciplinary background (immunology/biotechnology) to develop original research lines aimed at: 1-resolving remaining questions revolving granulocyte transfusions as a strategy for neutropenic infection treatments, and 2-dissecting human breastmilk-derived immunity. My laboratory recently evidenced significant regulations in B lymphocytes in breastmilk from mothers with obesity (published in BMC Medicine). Webpage.

Godfrey Bwire, MBCHB, MPH, PhD, Ministry of Health, Republic of Uganda
Godfrey Bwireorcid.org/0000-0002-8376-2857
Research interests: Cholera, infectious diseases, public health, epidemiology

Dr. Godfrey Bwire (MBChB, MPH, PhD) is a medical doctor, researcher and a policymaker. Godfrey is the head of the division of public health emergency preparedness and response of the Republic of Uganda Ministry of Health. Godfrey is also a research fellow in the department of Community Health and Behavioral Sciences, Makerere University School of Public Health. Godfrey’s research interests are on infectious diseases, public health and cholera. Godfrey et al. identified a new Vibrio Cholerae transmission event lineage (T13) from South Asia to East Africa, PMID: 29864113. Godfrey has an excellent peer-review record. Webpage.

Emily Edwards, PhD, Monash University, Australia
Emily Edwardsorcid.org/0000-0002-0240-4370
Research interests: Infectious diseases, primary immunodeficiency, immunology

Dr Edwards received her BSc (Hons) in Applied Biomedical Science at the University of Wales Institute Cardiff (UWIC), prior to completing a PhD at Cardiff University in the UK. She relocated to Australia in 2011. She has since conducted research at the QIMR Berghofer Medical Research Institute, Garvan Medical Research Institute and is currently a Postdoctoral Fellow at Monash University in Melbourne. Emily’s research focuses on the cellular and molecular pathways that underlie Primary Immunodeficiency, including identifying molecular and cellular patterns associated with viral infection, autoimmunity and gastrointestinal disease in these patients. Her research has identified new genetic causes of Primary Immunodeficiency, susceptibility to EBV and how these genetic defects influence immune pathway function, memory B and T cell function, and drive clinical disease. She is currently working to further understand primary immunodeficiencies, in order to examine the immune pathways altered in these diseases to better inform patient diagnosis and treatment. Webpage

Kwadwo Kusi, PhD, Noguchi Memorial Institute for Medical Research, University of Ghana, Ghana
Kwadwo Kusiorcid.org/0000-0001-5483-9985
Research interests: Cellular and humoral immunology of parasite and viral infections; Vaccine candidate discovery, design and testing; Pathogen biology

Dr. Kwadwo Asamoah Kusi is a Senior Research Fellow in the Immunology Department of Noguchi Memorial Institute for Medical Research (NMIMR), University of Ghana. He started his career at NMIMR in 2012 after graduating with a PhD in Medicine from Leiden University Medical Centre, based on his work at Biomedical Primate Research Centre in Rijswijk, The Netherlands. His research has been on assessing pathogen-induced cellular and humoral immune responses, with a special focus on Plasmodium falciparum. He is currently working on identifying HLA-restricted epitopes that elicit protection-associated T cell responses in individuals with a natural history of P. falciparum infection. He is principal investigator of an EDCTP2-funded Senior Fellowship that is investigating the impact of hepatitis B and Plasmodium co-infections on the liver. He is lead Immunologist on an on-going phase Ib clinical trial of an Inovio Pharmaceuticals Lassa fever vaccine at NMIMR as well as on a combined trial of measles/COVID-19 live vaccines for cross protection in Ghana, as part of a multi-centre trial under the CROWN CORONATION umbrella. He has on-going studies on multi-allele vaccine formulation strategies that aim to overcome the strain-dependent effects of polymorphisms in immunogenic Plasmodium antigens on antigen-specific immune responses. Webpage

Bartholomew Ondigo, PhD, Egerton University, Kenya
Bartholomew Ondigoorcid.org/0000-0003-3607-9964
Research interests: Global health, infectious diseases, immunology

Bartholomew completed a sandwich PhD degree program from Maseno University, Kenya and University of Minnesota, USA. He also completed postdoctoral training from an array of institutions, namely Kenya Medical Research Institute, University of Georgia, and Centers for Disease Control and Prevention, USA. Currently, he is an early career investigator at the department of Biochemistry and Molecular Biology, Egerton University, Kenya and a visiting post-doctoral fellow at National Institutes of Health, USA. His research interests focus on mechanisms of immunity and correlates of protection. Bartholomew particular focus is on pregnant women and children, the populations most susceptible to infectious diseases morbidity and mortality. He is interested in how people develop natural immunity to malaria, schistosomiasis and other tropical infectious diseases. In addition, he is interested in training and improving the prospects of graduate biomedical students. He is a member of several organizations including the American Society of Tropical Medicine and Hygiene, Royal Society of Tropical Medicine and Hygiene and the Kenyan Society of Immunology. Webpage.

Matthew Quaife, PhD, London School of Hygiene and Tropical Medicine, UK
Matthew (1)orcid.org/0000-0001-9291-1511
Research interests: Health economics, infectious disease modelling, TB, HIV, cost-effectiveness analyses, choice modelling

I am a health economist specialising in the prevention of infectious diseases, working at the interface of mathematical modelling and health economics. I enjoy the challenge of representing complex human behaviours in models and understanding how to encourage equitable and efficient health. My work mainly focuses on HIV and TB. Webpage.

Max Carlos Ramírez-Soto, BSc, MPH, FRSPH, PhD, Universidad de San Martín de Porres, Peru